Cargando…

Reply: Controversies on autoimmunity and prognosis in cancer

Detalles Bibliográficos
Autor principal:	Whiteside, T L
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2006
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2360518/ http://dx.doi.org/10.1038/sj.bjc.6603314

Ejemplares similares

Controversies on autoimmunity and prognosis in cancer
por: Ferretti, G, et al.
Publicado: (2006)

Reply: Optimum duration of breast cancer follow-up: a continuing controversy
por: Montgomery, D A, et al.
Publicado: (2007)

Reply: molecular determinants of prognosis in oesophageal cancer patients treated with chemoradiation
por: Yoshikawa, R, et al.
Publicado: (2008)

When controversies in null hypothesis significance testing prove to be controversial
por: Sedgwick, Philip M., et al.
Publicado: (2022)

Reply to “Subacute Combined Degeneration of the Spinal Cord Caused by Autoimmune Gastritis”
por: Ota, Kazuhiro, et al.
Publicado: (2020)

Reply to ‘Comment on ‘A meta-analysis of CXCL12 expression for cancer prognosis”
por: Gordon-Weeks, Alex
Publicado: (2018)

Reply: Value of tyrosinase RT–PCR in melanoma prognosis
por: Gogas, H
Publicado: (2003)

Controversy in Thyroid Disease
por: Bydder, Sean
Publicado: (2000)

Controversy in Thyroid Disease
por: Krentz, Andrew J
Publicado: (2000)

Lymphoid infiltration and prognosis in colorectal carcinoma: Dr. Sevennevig & Colleagues reply
por: Svennevig, J.L., et al.
Publicado: (1984)

Reply: The low responder according to the POSEIDON criteria: is the prognosis really poor?
por: Leijdekkers, Jori A, et al.
Publicado: (2019)

Euthanasia: A controversial debate
por: Nihal, Kanwal
Publicado: (2022)

Optimum duration of breast cancer follow-up: a continuing controversy
por: Maraqa, L, et al.
Publicado: (2007)

Reply to “Ivermectin Treatment May Improve the Prognosis of Patients With COVID-19”
por: Khan, Md. Saiful Islam, et al.
Publicado: (2021)

Reply to: “Association of chronic liver disease with the prognosis of COVID-19 patients”
por: Mallet, Vincent, et al.
Publicado: (2022)

Autoimmunity-related atrial fibrillation incidence: an emerging conundrum meriting further investigation: authors’ reply
por: Tilly, Martijn J, et al.
Publicado: (2023)

Celiac Disease and Autoimmunity: Review and Controversies
por: Denham, Jolanda M., et al.
Publicado: (2013)

Reply to the letter of Mahajan and Gaur in response to the article: Comorbidities in COVID-19: Outcomes in hypertensive cohort and controversies with renin angiotensin system blockers (Singh et al.)
por: Singh, Awadhesh Kumar, et al.
Publicado: (2020)

Public Health Controversies: Common Characteristics
por: Patil, Rajan R
Publicado: (2011)

Perioperative steroid supplementation: Controversies continues!!
por: Sethi, Priyanka, et al.
Publicado: (2017)

Reply
por: DeBiasi, Roberta L.
Publicado: (2020)

Reply
por: Rokosh, Rae S., et al.
Publicado: (2022)

Reply
por: Lokken, Erica M., et al.
Publicado: (2020)

Reply: Cancer care in rural areas
por: Campbell, N C, et al.
Publicado: (2004)

Reply to: “Comment on “Autoimmune hepatitis developing after coronavirus disease 2019 (COVID-19) vaccine: Causality or casualty?””
por: Bril, Fernando, et al.
Publicado: (2021)

“Settlement Agreement” a new controversial agreement
por: Ghooi, Ravindra Bhaskar
Publicado: (2016)

Current coronary intervention controversy: who's to judge?
por: Leonard, Roger
Publicado: (2011)

Infective Endocarditis: Controversies and Convictions in the Surgical Treatment
por: Spiliopoulos, Kyriakos, et al.
Publicado: (2023)

In Reply
por: Coomes, Eric A., et al.
Publicado: (2020)

Reply: Evaluating the activity of temsirolimus in neuroendocrine cancer
por: Duran, I, et al.
Publicado: (2007)

Reply
por: Yonker, Lael M., et al.
Publicado: (2021)

Reply
por: Yonker, Lael M., et al.
Publicado: (2021)

Reply: Ionising radiation and occupational cancer in Britain
por: Rushton, L, et al.
Publicado: (2012)

Authors’ reply
por: Teegala, Madhai L, et al.
Publicado: (2018)

Authors’ reply
por: Rao, Sanjay, et al.
Publicado: (2011)

Authors’ reply
por: Mishra, L D, et al.
Publicado: (2011)

Authors’ reply
por: Moura, Frederico Castelo, et al.
Publicado: (2010)

Authors’ reply
por: Gautam, Parshotam L., et al.
Publicado: (2012)

Authors’ reply
por: Krishna, Bhuvana, et al.
Publicado: (2014)

Author’s Reply
por: Najar, M. S., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_aolsgehte7qoh565crpt0b495l